Literature DB >> 20124987

The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells.

Yingfan Zhang1, Huanhai Liu, Jiyang Jin, Xiaohai Zhu, Lixuan Lu, Hua Jiang.   

Abstract

Rapid increases in incidence and mortality of human malignant melanoma are observed worldwide; thus, the development of new effective chemicals to control melanoma is urgent. In this study, the cytotoxic effect of oxymatrine, a natural quinolizidine alkaloid, against three human melanoma cell lines (A375, Sk-Mel-28, MM96L) and the underlying mechanisms were investigated. Oxymatrine killed all three human melanoma cell lines in a dose-dependent manner. The compound also dose-dependently caused apoptosis in human melanoma A375 cells. In addition, oxymatrine induced a remarkable change in mitochondrial membrane potential and triggered the release of cytochrome c from mitochondria to cytosol. Furthermore, this small compound resulted in a marked activation of capase-3, caspase-9, and poly (ADP-ribose) polymerase, while caspase-3 inhibitor Z-DEVD-FMK significantly reversed the proapoptotic effect of oxymatrine in A375 cells. Moreover, oxymatrine also dose-dependently increased the generation of reactive oxygen species in A375 cells, and N-acetylcysteine, a reactive oxygen species production inhibitor, almost completely blocked oxymatrine-induced apoptosis. In conclusion, our findings suggest that oxymatrine triggers oxidative stress, resulting in the collapse of the mitochondrial transmembrane potential, which in turn leads to cytochrome c release and apoptosis through the intrinsic caspase-9/caspase-3 pathway in human melanoma A375 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124987     DOI: 10.1097/CAD.0b013e328336e927

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  8 in total

1.  Neuroprotection induced by N-acetylcysteine and selenium against traumatic brain injury-induced apoptosis and calcium entry in hippocampus of rat.

Authors:  Mustafa Nazıroğlu; Nilgün Senol; Vahid Ghazizadeh; Vehbi Yürüker
Journal:  Cell Mol Neurobiol       Date:  2014-05-20       Impact factor: 5.046

2.  Oxymatrine attenuates diabetes-associated cognitive deficits in rats.

Authors:  Suo-bin Wang; Jian-ping Jia
Journal:  Acta Pharmacol Sin       Date:  2014-01-20       Impact factor: 6.150

3.  Saponins isolated from Asparagus induce apoptosis in human hepatoma cell line HepG2 through a mitochondrial-mediated pathway.

Authors:  Y Ji; C Ji; L Yue; H Xu
Journal:  Curr Oncol       Date:  2012-07       Impact factor: 3.677

4.  Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.

Authors:  Jun Fu; Bin Luo; Wen-Wen Guo; Qing-Mei Zhang; Lei Shi; Qi-Ping Hu; Fang Chen; Shao-Wen Xiao; Xiao-Xun Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

5.  Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation.

Authors:  Maria P Ikonomopoulou; Manuel A Fernandez-Rojo; Sandy S Pineda; Pablo Cabezas-Sainz; Brit Winnen; Rodrigo A V Morales; Andreas Brust; Laura Sánchez; Paul F Alewood; Grant A Ramm; John J Miles; Glenn F King
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

6.  Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway.

Authors:  Jun Zhang; Yanzhong Wang; Guiling Li; Haitao Yu; Xinyou Xie
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

7.  Oxymatrine suppresses the growth and invasion of MG63 cells by up-regulating PTEN and promoting its nuclear translocation.

Authors:  Ming He; Linlin Jiang; Bin Li; Guangbin Wang; Jiashi Wang; Yonghui Fu
Journal:  Oncotarget       Date:  2017-05-10

8.  Laminarin induces apoptosis of human colon cancer LOVO cells through a mitochondrial pathway.

Authors:  Yu Bin Ji; Chen Feng Ji; He Zhang
Journal:  Molecules       Date:  2012-08-20       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.